Citigroup’s AdaptHealth AHCO Stock Holding History

Citigroup’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-333,300	Closed	-$6.01M	–	5786
2022 Q2	$6.01M	Buy	+333,300	New	+$5.41M	﹤0.01%	1429

Other funds holding AHCO

OCA

OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citigroup's AHCO Position: Q2 2026 in Review

Citigroup reduced its AdaptHealth (AHCO) stake by 40% in Q2 2026, selling an estimated $431K and leaving 59,128 shares worth $616K. The position accounts for ﹤0.01% of the portfolio, ranked #3787.

Citigroup first reported a position in AHCO in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.73M in Q1 2025. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

Citigroup held 59,128 shares of AdaptHealth worth $616K as of Q2 2026.
Citigroup sold 38,610 AdaptHealth shares in Q2 2026, an estimated $431K.
AdaptHealth made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3787 holding.
Citigroup first reported a position in AdaptHealth in Q4 2019 and has held it in 27 quarters since.
Citigroup's AdaptHealth position peaked at $1.73M in Q1 2025.
239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.